Results 171 to 180 of about 42,628 (216)

Discontinuation of Cholinesterase Inhibitors Following Initiation of Memantine and Admission to Long-Term Care Among Older Adults.

JAMA Netw Open
Lee YC, Shi SM, Sison SM, Park CM, Oh G, Jeong S, McCarthy EP, Kim DH.   +7 more
europepmc   +1 more source

New Sulfonate Ester-Linked Fluorinated Hydrazone Derivatives as Multitarget Carbonic Anhydrase and Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, Molecular Docking and ADME Analysis. [PDF]

Chem Biodivers
Akış B, Çakmak R, Şentürk M.
europepmc   +1 more source

Moderation of Amyloid-β Deposition on the Effect of Cholinesterase Inhibitors on Cognition in Mild Cognitive Impairment. [PDF]

J Alzheimers Dis
Byeon G, Byun MS, Yi D, Ahn H, Jung G, Lee YS, Kim YK, Kang KM, Sohn CH, Lee DY, KBASE Research Group.   +10 more
europepmc   +1 more source

A Sustainable Synthetic Approach to Tacrine and Cholinesterase Inhibitors in Deep Eutectic Solvents under Aerobic Conditions. [PDF]

Molecules
Cicco L, Perna FM, Capriati V, Vitale P.
europepmc   +1 more source

Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies: An up to 10-year follow-up study. [PDF]

Alzheimers Dement
Xu H, Habich A, Ferreira D, Elisabet L, Westman E, Eriksdotter M.   +5 more
europepmc   +1 more source

Treating Vascular Dementia : Cholinesterase Inhibitors and …

Annals of Indian Academy of Neurology, 2004
Nagaraja D, Gangadhar B.N.
doaj  

Some of the next articles are maybe not open access.

Related searches:

Cholinesterase Inhibitors and Beyond

Current Alzheimer Research, 2009
Cholinesterase inhibitors (ChEIs) were introduced in the therapy of Alzheimer Disease (AD) in the nineteen nineties with great expectations. The hopes and large interest raised by these drugs are well demonstrated by 12,000 references listed by PubMed under 'ChEI' for 1995-2007. The list is reduced to 2500 if we confine ourselves to 'ChEIs and dementia'
PEPEU, GIANCARLO, GIOVANNINI, MARIA GRAZIA   +1 more
openaire   +2 more sources

The Cholinesterase Inhibitors

Journal of Psychiatric Practice, 2003
Dementia is a serious and growing problem that presents enormous burdens to patients, their families, and national healthcare systems throughout the world. In the United States, there are currently two classes of psychopharmacologic agents approved for the treatment of Alzheimer's disease: the cholinesterase inhibitors, which are approved for use in ...
openaire   +2 more sources

Cholinesterases and Cholinesterase Inhibitors

Archives of Neurology, 2001
1. Introduction 2. Cholinesterase Inhibitors: An Introduction 3. Molecular Structure of Cholinesterases and Complexes with Inhibitors 4. Rational Design of Cholinesterase Inhibitors 5. Genetics and Epigenetics of Mammalian Cholinesterases 6. The Gene Structure of Cholinesterases 7. Molecular Forms and Anchoring of Cholinesterases 8. Mechanism of Action
openaire   +1 more source